In bladder cancer miR-200b and miR-200c have been reported to reduce expression of ZEB1, ZEB2, and ErbB receptor inhibitor-1 and therefore inhibit EMT and restore epidermal growth factor receptor dependency [7]. The gene discussed is ZEB2; the disease is urinary bladder cancer.